Canadian Society of

Pharmacology and Therapeutics

Log in

Board of directors

Kerry Goralski, PhD (Halifax, Nova Scotia) – President

Kerry Goralski is a professor in the College of Pharmacy, Dalhousie University. He has a cross-appointment to the Department of Pharmacology and Department of Pediatrics, Dalhousie University and an Affiliated Research Staff Appointment in the Division of Pediatric Hematology/Oncology at the IWK Health Centre. He is a Senior Scientist in the Beatrice Hunter Cancer Research Institute. His research interests include obesity-associated cancers, multi-drug resistant metastatic breast cancer, and pharmacogenomics and precision medicine. He has been a member of the PSC/CSPT since 1996.

Bruce Carleton, PharmD, FCP, FISPE (Vancouver, British Columbia) – Vice-president

Bruce Carleton is Professor and Chair, Division of Clinical Pharmacology, Department of Pediatriics, University of British Columbia. He is a Senior Clinician Scientist at the BC Children’s Hospital Research Institute. He is also the CEO of the Canadian Pharmacogenomics Network for Drug Safety. He has a keen interest in advancing the safe and effective use of drugs, particularly in children. He is passionate about caring for kids.

Brad Urquhart, PhD (London, Ontario) – Treasurer

Brad Urquhart is Associate Professor in the Department of Physiology and Pharmacology and Associate Dean, Basic Medical Sciences Undergraduate Education at Western University. Brad has previously served on the CSPT scientific program committee and is currently the treasurer of CSPT. His research investigates mechanisms for variability in drug response and toxicity in kidney disease.

Eric Chen, PhD (Toronto, Ontario) – Scientific Program Committee Co-Chair

Thomas Velenosi, PhD (London, Ontario) – Scientific Program Committee Co-Chair

Fabiana Crowley, PhD (London, Ontario) – Education Committee Chair

Michael Rieder, MD, PhD, FRCPC, FAAP, FRPC (Edinburgh) (London, Ontario) – Past President

Michael Rieder holds the CIHR-GSK Chair in Paediatric Clinical Pharmacology at Western University in London and is a Scientist at the Robarts Research Institute. He is the Past President of CSPT and a member of the Drug Therapy Committee of the Canadian Paediatric Society. His research focus is on mechanistic studies of serious adverse drug reactions and drug safety as well as for optimal drug therapy for children.  

Doreen Matsui, MD, FRCPC (London, Ontario) – Director-at-Large and RCPSC Liaison

Doreen Matsui is Professor Emeritus, Department of Paediatrics, Western University. She is a member of the Royal College of Physicians and Surgeons of Canada (RCPSC) Specialty Committee in Clinical Pharmacology and Toxicology. Doreen is also a member of the RCPSC Examination Board in Clinical Pharmacology and Toxicology as Past-Chair.

Copyright© 2020

Canadian Society of Pharmacology and Therapeutics (CSPT)

All rights reserved.




Powered by Wild Apricot Membership Software